Sales and Marketing

Showing 15 posts of 11527 posts found.

Novartis to build $500 million biotech facility in Singapore

November 1, 2012 Manufacturing and Production, Sales and Marketing Jimenez, M&P, Novartis, Singapore

Novartis is overseeing the construction of a biotechnology facility in Singapore that is the result of a $500m investment injection. …

Inspired Science appoints principal medical writer

October 31, 2012 Medical Communications, Sales and Marketing Inspired Science, Peter Levantis

Med comms firm Inspired Science has announced the appointment of Dr Peter Levantis as principal medical writer. In this newly …

Diabetes softens generics blow for Sanofi

October 30, 2012 Sales and Marketing Eloxatin, Plavix, Sanofi, diabetes, emerging markets, patent cliff

Sanofi has unveiled its results for the third quarter, with news that the damage done by patent expiries has not …

Lilly appoints new chief ethics and compliance officer and senior VP

October 30, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Melissa Barnes, lilly

Eli Lilly has announced that Melissa Barnes will be promoted to chief ethics and compliance officer and senior vice president …

Shionogi and ViiV strike new HIV deal

October 30, 2012 Research and Development, Sales and Marketing Atripla, Dolutegravir, HIV, Shionogi, ViiV

HIV specialist firm ViiV Healthcare has announced a new deal with Japan’s Shionogi on a promising new treatment. ViiV Healthcare …

Pharmalink AB strengthens senior management

October 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Heather Cook, Marek Poszepczynski, Pharmalink AB

Pharmalink AB has appointed Heather Cook as director of Regulatory Affairs and Marek Poszepczynski as director of Business Development. Cook …

Teva’s CML drug approved

October 29, 2012 Research and Development, Sales and Marketing FDA, Synribo, Teva

Teva’s new treatment for chronic myeloid leukemia Synribo has been approved by the FDA. Synribo (omacetaxine mepesuccinate) is an injectable …

Almirall welcomes UCB head into Board of directors

October 29, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Almirall, Gerhard Mayr

Almirall has approved the appointment of Gerhard Mayr as a new independent member to its Board of directors. He is …

EU countries suspend sales of Novartis flu vaccines

October 29, 2012 Manufacturing and Production, Sales and Marketing EU, Novartis, vaccines

Contamination of Novartis flu vaccines with white particles has resulted in regulatory actions from various authorities in the EU, including …

The NHS revolution – one wave at a time

October 26, 2012 Sales and Marketing CCGs, NHS, pharma-NHS partnerships

 The first group of prospective Clinical Commissioning Groups (CCGs) will have to wait a little longer to hear if they …

Turning business intelligence managers into business performance leaders

October 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, MSI, business leaders, intelligence

Never before have business intelligence people played such a leading role in the marketing planning process. For those who view …

Sharp fall for AstraZeneca

October 26, 2012 Sales and Marketing AstraZeneca, Brennan, Q3, Soriot

AstraZeneca saw its third quarter revenue and pre-tax profit both fall 15%, to $6.7 billion and $2 billion, respectively. The …

Astellas announces compliance officer for the Americas

October 26, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Astellas, McCauley

Astellas recently named J. Patrick McCauley Jr, a longtime pharmaceutical industry veteran and Astellas employee, to the post of Regional …

Shire poaches new head from Bayer

October 26, 2012 Sales and Marketing Angus Russell, Flemming Omskov, Shire

Flemming Ornskov, currently chief marketing officer at Bayer, is to take over at Dublin-based Shire Pharmaceuticals next year. He will …

Lilly censured for rep photo

October 25, 2012 Medical Communications, Sales and Marketing ABPI, GP, PMCPA, lilly

Lilly has breached the ABPI’s Code of Practice because one of its representatives insisted on taking pictures of doctors underneath …
The Gateway to Local Adoption Series

Latest content